Long-term survival after treatment with gemcitabine and oxaliplatin with and without paclitaxel plus secondary surgery in patients with cisplatin-refractory and/or multiply relapsed germ cell tumors.
Related Research units
Abstract
Chemotherapy including gemcitabine, oxaliplatin, and/or paclitaxel has shown efficacy in germ cell tumor patients after progression during cisplatin-based chemotherapy or relapse after high-dose chemotherapy including complete responses in 5-15%.
Bibliographical data
| Original language | English |
|---|---|
| Article number | 4 |
| ISSN | 0302-2838 |
| Publication status | Published - 2011 |
| pubmed | 21704446 |
|---|
